Moleculin Biotech
MBRX
MBRX
22 hedge funds and large institutions have $2.04M invested in Moleculin Biotech in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$46.6K | |
| 2 | +$44.7K | |
| 3 | +$21K | |
| 4 |
WIC
Woodmont Investment Counsel
Nashville,
Tennessee
|
+$10K |
| 5 |
Squarepoint
New York
|
+$10K |
Top Sellers
| 1 | -$180K | |
| 2 | -$67K | |
| 3 | -$26.9K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$21.8K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$6K |